Development of a first-in-class therapeutic for protecting the ischemic heart [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Heart disease is the leading cause of death globally. Heart attacks are the primary cause of death associated with heart disease. We have discovered a drug, Hi1a, that blocks the injury response of the heart when a heart attack happens. There are no other drugs currently available or in the discovery pipeline that address this problem. This proposal will use models of injury to the heart as well as safety studies to help develop Hi1a as a new drug for people who suffer from heart attacks.

Funding Amount $926,673

Funding Scheme Development Grants

Chief Investigator Dr Nathan Palpant

Notes Development Grant